Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Imdevimab Emergency use authorization Experimental Antiviral Jan/23/2023 32 11
Casirivimab Emergency use authorization Experimental Antiviral Jan/23/2023 27 16
Bamlanivimab Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022 11 16
BNT162b2 Approved by FDA Experimental Vaccine Jun/22/2022 65 0
mRNA-1273 Emergency use authorization Experimental Vaccine Jun/22/2022 27 1
REGEN-COV Emergency use authorization Experimental Antiviral Jun/03/2022 11 1
ACE2‐Fc Potential treatment - pre-clinical evidence Experimental Antiviral Apr/26/2022 5 0
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021 18 8
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021 12 1
Excel (.xslx) CSV (.csv)